Sawai Group Holdings Co., Ltd.
JPX: 4887.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mitsuo Sawai
- Employees
- 3,482
- Headquarters
- Osaka, Japan
- IPO year
- 2021
- Market cap
- ¥242.8B
- Website
- https://www.sawaigroup.holdings
Loading 4887…
Loading profile data…Frequently asked questions about 4887
What does Sawai Group Holdings Co., Ltd. (4887.T) do?
Sawai Group Holdings Co., Ltd., together with subsidiaries, engages in the research, development, manufacturing, and marketing of generic pharmaceutical products primarily in Japan and the United States. It offers generic drugs in various dosage forms, including tablets, oral dispersing tablets, capsules, granules, injectables, tapes, ophthalmic...
Where does 4887.T trade?
Sawai Group Holdings Co., Ltd. (4887.T) trades on the Tokyo Stock Exchange.
What sector is 4887.T in?
Sawai Group Holdings Co., Ltd. (4887.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Sawai Group Holdings Co., Ltd.?
Mitsuo Sawai is the chief executive officer of Sawai Group Holdings Co., Ltd. (4887.T).
Where is Sawai Group Holdings Co., Ltd. headquartered?
Sawai Group Holdings Co., Ltd. is headquartered in Japan.
Does 4887.T pay a dividend?
Yes — Sawai Group Holdings Co., Ltd. (4887.T) paid a trailing twelve-month dividend of JPY 55.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4887.T go public?
Sawai Group Holdings Co., Ltd. (4887.T) completed its initial public offering in 2021.